Agaricus blazei polysaccharide
1 professional manufacturer of mushroom polysaccharide
2 active ingredient:polysaccharide

Agaricus blazei polysaccharide

1 specification:20%-40%

2 active ingredient:polysaccharide

Description of Polysaccharides

Polysaccharides are structures of polymeric carbohydrate, formed of glacosidic bonds repeating units (either mono- or di-saccharides) joined together by . These structures are often linear, but may contain various degrees of branching. Polysaccharides are often quite heterogeneous, containing slight modifications of the repeating unit. Depending on the structure, these can have distinct properties from their monosaccharide building blocks. They may be amorphous or even insoluble in water.

Agaricus subrufescens (incorrectly known as Agaricus blazei, Agaricus sylvaticus) is a species of mushroom , commonly known as Agaricus Blazei Murill Mushroom, Almond mushroom, or himematsutake and by a number of other names. Agaricus subrufescens is a choice edible, with a somewhat sweet taste and fragrance of . This mushroom is also well known as a medicinal mushroom, for its purported medicinal properties, due to research which indicates it may stimulate the immune system.

Function and Application 

Due to the fact Agaricus subrufescens contains a high level of beta glucans, compounds known for stimulating the immune system, the fungus is used in in Japan and . In addition to beta-glucans, the mushroom's effect on the immune system is believed to be due to other polysaccharides such as alpha-glucans. In Japan, Agaricus subrufescens is sold under the brand names Sen-Sei-Ro Gold, and ABMK, and is used by an estimated 500,000 people In Japan, Agaricus subrufescens is also the most popular complementary and alternative medicine used by cancer patients. Although Agaricus subrufescens is cultivated in the United States, the largest exporters are China and . It has been noted in a scientific review of A. subrufescens research, that the range of quality in A. subrufescens cultivation can affect the mushroom's ability to impact cells of the immune system.

Recently, Watanabe et al. published a report in the Biological & Pharmaceutical Bulletin on a novel hybrid of A. subrufescens called Basidiomycetes-X (BDM-X) and a US patent was issued on a novel hybrid of the A. subrufescens edible mushroom which was cross-bred (hybridized) with another medicinal mushroom resulting in a new hybrid claimed to possess 10 to 3000 times the potency of similar but unpatented mushrooms.

Should need anything update, pls contact me freely.